Comparative Analysis of Antigen-Targeting Sequences Used in DNA Vaccines

被引:3
作者
Carvalho, Joana A. [1 ]
Azzoni, Adriano R. [1 ]
Prazeres, Duarte M. F. [1 ]
Monteiro, Gabriel A. [1 ]
机构
[1] Univ Tecn Lisboa, Ctr Biol & Chem Engn, IBB, Inst Super Tecn, P-1049001 Lisbon, Portugal
关键词
DNA vaccines; Plasmid DNA; Vector design; Antigen targeting; Antigen processing pathways; CYTOTOXIC T-LYMPHOCYTES; PLASMID DNA; MEMBRANE PROTEIN-1; IMMUNE-RESPONSES; GENE-EXPRESSION; DELIVERY; IMMUNOGENICITY; CELL; OPTIMIZATION; VECTORS;
D O I
10.1007/s12033-009-9229-x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Plasmid vectors can be optimized by including specific signals that promote antigen targeting to the major antigen presentation and processing pathways, increasing the immunogenicity and potency of DNA vaccines. A pVAX1-based backbone was used to encode the Green Fluorescence Protein (GFP) reporter gene fused either to ISG (Invariant Surface Glycoprotein) or to TSA (trans-sialidase) Trypanosoma brucei genes. The plasmids were further engineered to carry antigen-targeting sequences, which promote protein transport to the extracellular space (secretion signal), lysosomes (LAMP-1) and to the endoplasmic reticulum (adenovirus e1a). Transfection efficiency was not affected by differences in the size between each construct as no differences in the plasmid copy number per cell were found. This finding also suggests that the addition of both ISG gene and targeting sequences did not add sensitive regions prone to nuclease attack to the plasmid. Cells transfected with pVAX1GFP had a significant higher number of transcripts. This could be a result of lower mRNA stability and/or a lower transcription rate associated with the bigger transcripts. On the other hand, no differences were found between transcript levels of each ISG-GFP plasmids. Therefore, the addition of these targeting sequences does not affect the maturation/stability of the transcripts. Microscopy analysis showed differences in protein localization and fluorescent levels of cells transfected with pVAX1GFP and ISG constructs. Moreover, cells transfected with the lamp and secretory sequences presented a distinct distribution pattern when compared with ISG protein. Protein expression was quantified by flow cytometry. Higher cell fluorescence was observed in cells expressing the cytoplasmic fusion protein (ISG-GFP or TSA-GFP) compared with cells where the protein was transported to the lysosomal pathway. Protein transport to the endoplasmic reticulum does not lead to a decrease in the mean fluorescence values. The secretion signal was only effective when used in conjunction with TSA gene. Therefore, the characteristics of each protein (e.g., presence of transmembrane domains) might influence the efficacy of its cellular transport. This analysis constitutes a useful tool for the optimization of the design of DNA vaccines.
引用
收藏
页码:204 / 212
页数:9
相关论文
共 49 条
[1]   Maximizing antigen targeting to the proteasome for gene-based vaccines [J].
Andersson, HA ;
Barry, MA .
MOLECULAR THERAPY, 2004, 10 (03) :432-446
[2]   Dendritic cell-lysosomal-associated membrane protein (LAMP) and LAMP-1-HIV-1 Gag chimeras have distinct cellular trafficking pathways and prime T and B cell responses to a diverse repertoire of epitopes [J].
Arruda, Luciana B. ;
Sim, Del ;
Chikhlikar, Priya R. ;
Maciel, Milton, Jr. ;
Akasaki, Kenji ;
August, J. Thomas ;
Marques, Ernesto T. A. .
JOURNAL OF IMMUNOLOGY, 2006, 177 (04) :2265-2275
[3]   The impact of polyadenylation signals on plasmid nuclease-resistance and transgene expression [J].
Azzoni, Adriano R. ;
Ribeiro, Sofia C. ;
Monteiro, Gabriel A. ;
Prazeres, Duarte M. F. .
JOURNAL OF GENE MEDICINE, 2007, 9 (05) :392-402
[4]   A human T-cell leukemia virus type 1 regulatory element enhances the immunogenicity of human immunodeficiency virus type 1 DNA vaccines in mice and nonhuman primates [J].
Barouch, DH ;
Yang, ZY ;
Kong, WP ;
Korioth-Schmitz, B ;
Sumida, SM ;
Truitt, DM ;
Kishko, MG ;
Arthur, JC ;
Miura, A ;
Mascola, JR ;
Letvin, NL ;
Nabel, GJ .
JOURNAL OF VIROLOGY, 2005, 79 (14) :8828-8834
[5]   Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination [J].
Barouch, DH ;
Santra, S ;
Schmitz, JE ;
Kuroda, MJ ;
Fu, TM ;
Wagner, W ;
Bilska, M ;
Craiu, A ;
Zheng, XX ;
Krivulka, GR ;
Beaudry, K ;
Lifton, MA ;
Nickerson, CE ;
Trigona, WL ;
Punt, K ;
Freed, DC ;
Guan, LM ;
Dubey, S ;
Casimiro, D ;
Simon, A ;
Davies, ME ;
Chastain, M ;
Strom, TB ;
Gelman, RS ;
Montefiori, DC ;
Lewis, MG ;
Emini, EA ;
Shiver, JW ;
Letvin, NL .
SCIENCE, 2000, 290 (5491) :486-492
[6]   DNA vaccination and gene therapy: optimization and delivery for cancer therapy [J].
Bodles-Brakhop, Angela M. ;
Draghia-Akli, Ruxandra .
EXPERT REVIEW OF VACCINES, 2008, 7 (07) :1085-1101
[7]   Influence of cellular location of expressed antigen on the efficacy of DNA vaccination: cytotoxic T lymphocyte and antibody responses are suboptimal when antigen is cytoplasmic after intramuscular DNA immunization [J].
Boyle, JS ;
Koniaras, C ;
Lew, AM .
INTERNATIONAL IMMUNOLOGY, 1997, 9 (12) :1897-1906
[8]   Time-course determination of plasmid content in eukaryotic and prokaryotic cells using Real-Time PCR [J].
Carapuca, Elisabete ;
Azzoni, Adriano R. ;
Prazeres, Duarte M. F. ;
Monteiro, Gabriel A. ;
Mergulhao, Filipe J. M. .
MOLECULAR BIOTECHNOLOGY, 2007, 37 (02) :120-126
[9]  
Carvalho JA, 2009, IDRUGS, V12, P642
[10]   Plasmid encoding papillomavirus type 16 (HPV 16) DNA constructed with codon optimization improved the immunogenicity against HPV infection [J].
Cheung, YK ;
Cheng, SCS ;
Sin, FWY ;
Xie, Y .
VACCINE, 2004, 23 (05) :629-638